Ligand Pharmaceuticals Inc (NASDAQ:LGND)

167.22
Delayed Data
As of Apr 23
 +0.24 / +0.14%
Today’s Change
104.25
Today|||52-Week Range
184.79
+22.12%
Year-to-Date
Catalyst Enrolls First Patient in Phase III Firdapse Study
Apr 20 / Zacks.com - Paid Partner Content
Verastem (VSTM) in Focus: Stock Moves 8% Higher
Apr 13 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Gets Priority Review for Lung Cancer
Apr 19 / Zacks.com - Paid Partner Content
FDA Lifts Clinical Hold on Bellicum's (BLCM) T Cell Therapy
Apr 12 / Zacks.com - Paid Partner Content
Calithera's Kidney Cancer Candidate Gets Fast Track Status
Apr 19 / Zacks.com - Paid Partner Content
Zacks.com featured highlights include: Ligand, ArcelorMittal, 58.com, Ameresco and M...
Apr 12 / Zacks.com - Paid Partner Content
Bayer to Divest 3.6% Stake to Singapore Company Temasek
Apr 18 / Zacks.com - Paid Partner Content
Epizyme (EPZM) Publishes Tazemetostat Phase I Data, Stock Up
Apr 11 / Zacks.com - Paid Partner Content
Agios' Leukemia Drug Bodes Well for Growth & Strong Pipeline
Apr 18 / Zacks.com - Paid Partner Content
Karyopharm's Myeloma Candidate Gets Fast Track Designation
Apr 11 / Zacks.com - Paid Partner Content
Alnylam (ALNY) Reports Positive Data for RNAi Candidate
Apr 17 / Zacks.com - Paid Partner Content
FDA Prolongs Review Date for AbbVie Endometriosis Candidate
Apr 11 / Zacks.com - Paid Partner Content
Alkermes Rallies as FDA Accepts NDA for Depression Drug
Apr 17 / Zacks.com - Paid Partner Content
5 Best Profitable Stocks Offering Amazing Returns
Apr 11 / Zacks.com - Paid Partner Content
Merck's Keytruda Betters Survival in Lung Cancer Combo Study
Apr 17 / Zacks.com - Paid Partner Content
FDA Restricts Sale of Bayer's Essure Birth Control Device
Apr 10 / Zacks.com - Paid Partner Content
Intercept Reports Phase III Sub-Study Liver Biopsy Data
Apr 16 / Zacks.com - Paid Partner Content
Ionis (IONS) Clinches Licensing Agreement with AstraZeneca
Apr 10 / Zacks.com - Paid Partner Content
Rigel Pharmaceuticals' (RIGL) Stock Gains 16%: Here's Why
Apr 13 / Zacks.com - Paid Partner Content